Similar articles

• Influenza vaccine for 2015-2016.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2015 Sep 14;57(1477):125-7. Med Lett Drugs Ther. 2015. PMID: 26353043 Review. No abstract available.
• MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.

  O'Hagan DT. O'Hagan DT. Expert Rev Vaccines. 2007 Oct;6(5):699-710. doi: 10.1586/14760584.6.5.699. Expert Rev Vaccines. 2007. PMID: 17931151 Review.
• Influenza vaccine efficacy trials: a simulation approach to understand failures from the past.

  Benoit A, Legrand C, Dewé W. Benoit A, et al. Pharm Stat. 2015 Jul-Aug;14(4):294-301. doi: 10.1002/pst.1685. Epub 2015 Apr 30. Pharm Stat. 2015. PMID: 25924929
• A dynamical model for influenza under seasonal variables.

  Taherian M, Toomanian M, Molaei M. Taherian M, et al. Theor Biol Forum. 2014;107(1-2):151-62. Theor Biol Forum. 2014. PMID: 25936220
• Assessing vaccine efficacy in influenza clinical trials: challenges and difficulties.

  Dewe W, Benoit A, Legrand C. Dewe W, et al. Expert Rev Clin Pharmacol. 2013 Jul;6(4):403-11. doi: 10.1586/17512433.2013.811817. Expert Rev Clin Pharmacol. 2013. PMID: 23927668 Review.